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Jussara Vono,2 and Geraldo Medeiros-Neto2
In this work we have extended our initial molecular studies of a consanguineous family with two affected
goitrous siblings (H.S.N. and Ac.S.N.) with defective thyroglobulin (Tg) synthesis and secretion because of a
homozygotic deletion of a fragment of 138 nucleotides (nt) in the central region of the Tg mRNA, identified
previously in H.S.N. In order to identify the intron/exon boundaries and to analyze the regions responsible
for pre-mRNA processing corresponding to a 138 nt deletion, we performed a screening of a human genomic
library. The intron/exon junction sequences were determined from one positive clone by sequencing both
strands of the DNA template. The results showed that the deletion mapped between positions 5549 and 5686
of the Tg mRNA and corresponded to exon 30. The positions of the exon limits differed by three nucleotides
from the previously reported data obtained from direct sequencing of the deleted reverse transcriptase-poly-
merase chain reaction fragment from H.S.N. These variations are because the intron/exon junctions in this re-
gion were not available at the time when the deletion was first described. The deletion does not affect the read-
ing frame of the resulting mRNA and is potentially fully translatable into a Tg polypeptide chain that is
shortened by 46 residues. The same 138 nt deletion was observed in reverse transcriptase-polymerase chain re-
action studies performed in the thyroid tissues from Ac.S.N. Genomic DNA analysis showed that a G to T trans-
version was observed at position 11 in the donor site of intron 30. Both affected patients (H.S.N. and Ac.S.N.)
are homozygous for the mutation whereas the normal sister (At.S.N.) had a normal allele pattern. The func-
tional consequences of the deletion are related to structural changes in the protein molecule that either could
modify the normal routing of the translation product through the membrane system of the cell or could im-
pair the coupling reaction. Probably the mutant Tg polypeptide might be functionally active in the production
of thyroid hormone, because in the presence of a normal iodine ingestion (, 150 mg/day), Ac.S.N. was able to
maintain normal serum levels of total triiodothyronine (T3) associated with relatively low serum total thyrox-
ine (T4) with normal somatic development without signs of brain damage.
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Introduction
THYROGLOBULIN (Tg) is a large glycoprotein that functionsas the matrix for thyroid hormone synthesis and in stor-
age of the inactive form of thyroid hormone and of iodine
(1). The human Tg gene is a 300-kb unit containing 8.5 kb of
exon material, localized in chromosome 8 (8q24.2—8q24.3)
(1). The number of exons has been estimated as 48 (2). Sev-
eral mutations in the Tg gene have been reported and are as-
sociated with congenital goiter and variable degrees of hy-
pothyroidism (3–8).
Ieiri et al. (3) reported a hypothyroid woman with con-
genital goiter and marked impairment of Tg synthesis. Mo-
lecular studies revealed that exon 4 was missing from the
major Tg transcript in the goiter and that this aberrant splic-
ing was due to a C to G transversion at position 23 in the
acceptor splice site of intron 3.
A cytosine to thymine transition creating a stop codon at
position 1511 in exon 22 has been described in a study of
family with congenital goiter (4). Two siblings were affected
with goiter and hypothyroidism, whereas the father and
three other siblings had normal thyroid function. However,
were heterozygous for the nonsense mutation. This implies
that an additional mutation must be present in the affected
individuals, generating a compound heterozygote genotype
(5).
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More recently, van de Graaf et al. (6) identified a C to T
transition at nucleotide (nt) position 886 in exon 7, creating
a stop codon at amino acid Arg 277 in three siblings from a
consanguineous marriage, with goiter and a moderate de-
gree of hypothyroidism. Additional analysis of the pedigree
indicated that the homozygous nonsense mutation cosegre-
gated with the clinical phenotype.
Another report has indicated that cysteine substitutions
(C1245R and C1977S in exons 17 and 33, respectively) cause
an abnormal three-dimensional structure of Tg and defective
intracellular transport of Tg (7).
We have previously identified a 138-nt deletion in the Tg
mRNA in one member of a family with a history of con-
genital goiter (8). The affected members (two siblings) had
congenital goiter, variable degrees of hypothyroidism, and
marked impairment of Tg synthesis. The diagnosis of defec-
tive Tg was based on low serum total thyroxine (T4), low
serum total triiodothyronine (T3) (H.S.N.) or normal serum
total T3 (Ac.S.N.), a negative perchlorate discharge test, and
the virtual absence of the serum Tg response to challenge by
bovine thyrotropin (TSH).
In the present article, we extend our initial molecular stud-
ies to show that the affected members of this family have an
aberrant splicing because of a G to T transvertion at position
11 in the donor splice site of intron 30.
Materials and Methods
Patients
This work was approved by the Ethical Committee of the
Hospital das Clínicas, University of Sao Paulo Medical School,
and informed consent was obtained from the patients.
A detailed clinical and laboratory evaluation of this con-
sanguineous family has been reported previously (8). In
brief, H.S.N., a 20-year-old male, had lived most of his life
in an iodine-deficient area (Bahia), had congenital goiter and
hypothyroidism, but seldom took the prescribed levothy-
roxine (LT4) tablets. In spite of high levels of serum TSH and
a multinodular goiter, serum Tg concentrations were below
the limit of detection and did not increase after bovine TSH
stimulation. Both siblings (H.S.N. and Ac.S.N.) underwent
thyroidectomy because of compression symptoms caused by
the presence of a large multinodular goiter. Only minute
amounts of immunoassayable Tg-related antigens were de-
tected by radioimmunometric assay in the goitrous tissue.
Agarose gel electrophoresis of the denatured soluble protein
fraction (SPF) confirmed the virtual absence of Tg in the thy-
roid gland. In both siblings, Tg mRNA was isolated from the
goitrous tissues. Subsequently it was documented that
H.S.N. had a 138-nt deletion in the central region of the Tg
mRNA (8). His affected sister (Ac.S.N.), an 11-year-old
goitrous girl, had only mild signs of hypothyroidism and de-
veloped normally. The family had moved from a small vil-
lage in the state of Bahia to Sao Paulo when Ac.S.N. was ap-
proximately 2 years old. Therefore, for most of her life,
As.S.N. had a normal level of iodine ingestion through con-
stant use of iodized salt (40–100 mg/kg). Serum Tg basal lev-
els were low (1.0 mg/L) with a small increase to 2.9 mg/L af-
ter bovine TSH stimulation.
Another clinically normal sister (At.S.N.), had normal thy-
roid function tests and normal serum Tg levels.
Screening of a human genome library
An aliquot of a human genomic library made of l Dash II
recombinant phages (Stratagene, La Jolla, Ca) was plated on
Escherichia coli XL1-BlueMRA and screened by the filter
replica method using reverse transcriptase-polymerase chain
reaction (RT-PCR) fragments as hybridization probes: PCR
2.2, PCR 3.1, PCR 3.2, and PCR 3.3 (9). The probes mapping
in the central region of the Tg mRNA (nt 3012–6010), ac-
cording to new cDNA numbering. Prehybridization, hy-
bridization, and washing of the filters were performed as de-
scribed by Mendive et al. (2).
Screening of recombinant positive phages by PCR and
DNA sequencing of recombinant phages
The DNA from aliquots of the each positive phage stocks,
obtained in the screening by plate hybridization, was puri-
fied by proteinase K treatment and phenol extraction.
The polymerase chain reaction (PCR) was performed in
100 mL, using a standard PCR buffer (Gibco BRL, Life Tech-
nology, Gaithersburg, MD), containing 2.5 mM MgCl2, 200
mM each dNTP (dATP, dCTP, dTTP, and dGTP), 4% di-
methylsulfoxide, 2 units Taq polymerase (Gibco BRL) and 50
pmol of each reverse and forward primers. The samples were
subjected to 40 cycles of amplification. Each cycle consisted
of denaturation at 95°C for 30 seconds, primer annealing at
55°C for 30 seconds, and primer extension at 72°C for 1
minute. The primers used for PCR amplification were: for-
ward primer (EX 30 F): 59 TGACAACAGAACTTTTCTCC 39
and reverse primer (EX 30 R): 59 acGAGAAAGGCAC-
CATAGG 39 (Fig. 1). The amplified products, 138 bp, were
analyzed in a 2% agarose gel. The preparation of bacterio-
phage DNA was performed with Wizard lambda preps DNA
purification system (Promega, Madison, WI).
The exon and intron/exon junctions DNA sequences were
determined from l phage clone isolated using the Taq poly-
merase-based chain terminator method (fmol, Promega) and
the same exonic primers that were used for screening of re-
combinant positive phages by PCR.
RT-PCR amplification
Total RNA was prepared from human thyroid by the
method of Chomczynski and Sacchi (10). The primers, am-
plified regions, and conditions used for RT-PCR were de-
scribed previously (4,9).
Genomic PCR amplification and DNA sequencing
Leukocyte DNA was prepared by the sodium dodecyl sul-
fate (SDS)-proteinase K method. For this PCR reaction, the
same PCR conditions as those described above were used.
The primers used for PCR amplification were: forward
primer (IN 29 F): 59 gaactattcctgtctgaccc 39 and reverse
primer (IN 30 R): 59 ccacagtgatccatgagttatgacac 39 (Fig. 1).
The preparation of PCR amplification fragments was per-
formed with Concert gel purification system (Gibco BRL).
The exon and intron/exon junctions DNA sequences were
determinated with the Taq polymerase-based chain termi-
nator method (fmol, Promega) and the same intronic primers
that were used for genomic PCR amplification.
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Results
Characterization of intron 29/exon 30/intron 30 junction
In order to identify the intron/exon boundaries and to an-
alyze the regions responsible for pre-mRNA processing cor-
responding a 138-nt deletion in the Tg mRNA of H.S.N., we
performed a screening of a human genomic library.
About 1.9 3 106 phages of a human genomic DNA library
were screened by plaque hybridization with RT-PCR probes
corresponding to 3 kb from the central region of the Tg
mRNA. Fifty plaques were scored as positive. DNA was pre-
pared from each recombinant positive phage stocks and ex-
onic primers were used to perform PCR (see Materials and
Methods). The predicted 138-bp amplified fragment was ob-
served in 3 of the 16 stocks investigated and the intron/exon
junction sequences were determined from one positive clone
by sequencing both strands of the DNA template. The re-
sults showed that the 138-nt deletion mapped (Fig. 1) be-
tween positions 5549 and 5686 of the Tg mRNA and corre-
sponded to exon 30. The positions of the exon limits differed
by 3 nt from the previously reported data obtained from di-
rect sequencing of the deleted RT-PCR fragment from H.S.N.
(8). These variations are due to the intron/exon junctions in
this region that contains the deletion of H.S.N. were not
available at time when the deletion was first described.
RT-PCR analysis
The Tg mRNA from control and Ac.S.N.’s thyroid tissue
were first reverse transcribed and then divided into several
positions (16–8410) and the resulting complementary DNAs
were amplified individually by PCR. Analysis by 1.5%
agarose gel electrophoresis of the products showed the ex-
pected sizes in all amplified fragments, except for that cor-
responding to the region between positions 5127–6010 (PCR
3.3 fragment [9]) that lacked the normal 884-bp fragment.
The approximate size of the amplified fragment was 750 bp.
Sequencing of the smaller Ac.S.N. revealed that 138 bp were
missing between positions 5549 and 5686 of the TG mRNA.
Subsequently, we concluded that the region absent corre-
sponded to exon 30. These results are in perfect agreement
with the data obtained previously in the thyroid tissue of
H.S.N. (8).
This deletion does not affect the reading frame of the re-
sulting mRNA and is potentially fully translatable into a Tg
polypeptide chain that is shorter by 46 residues. A glycine
residue is maintained by the junction between the proximal
G from glycine 1831 and the distal GT from arginine 1877.
The predicted TG translation product is a madure protein of
2703 amino acids with an expected , 323,000 daltons.
Genomic DNA analysis
The splice sites bordering exon 30 were PCR amplified and
sequenced from genomic DNA of the goitrous patients
(H.S.N. and Ac.S.N.), their normal sister (At.S.N.), and one
normal control. A G to T transversion (Fig. 2) was observed
at position 11 in the donor site of intron 30 of the patients,
as compared to the normal sequence (TT instead of GT). The
sequence analysis showed that both patients, H.S.N. and
Ac.S.N., are homozygous for the mutation, whereas the
healthy sibling (At.S.N.) had the two normal alleles.
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FIG. 1. Nucleotide and deduced amino acid sequence of the thyroglobulin (Tg) gene exon 30 and intron 29/exon 30/in-
tron 30 junction sequences. The exon mapped between positions 5549 and 5686 of the Tg mRNA. The exonic sequences are
indicated by capital letters and the intronic sequences by lower-case letters. The positions of the amplification and sequence
primers are underlined. S indicates undetermined nucleotide.
Discussion
The rapid accumulation of knowledge by the introduction
of molecular biology in the field of thyroid genetic diseases
has modified some physiopathological concepts and im-
proved the diagnosis of resulting diseases. Prevalence of con-
genital hypothyroidism according to data from newborn
screening programs is estimated to be 1 in 4,000 (ranging
from 1 in 2,000 to 1 in 8,000). Patients with this heterogenous
clinical and biochemical disorder can be divided into two
groups: nongoitrous and goitrous neonatal hypothyroidism.
Nongoitrous neonatal hypothyroidism results from thyroid
gland agenesis (athyreosis), dysgenesis (ectopic gland), and
hypoplasic thyroid gland. In most cases, the etiology is un-
known. In a few patients, however, the congenital hypothy-
roidism is associated with mutations in genes responsible for
the development of thyroid follicular cells: TSH-b (11), TTF-
1 (12), PAX-8 (13), and TSH receptor genes (14). The pres-
ence of congenital goiter usually results from a number of
abnormalities related to the protein components of thyroid
hormonogenesis. Mutations in NIS symporter, Tg, thyroid
peroxidase (TPO), and pendrin genes originate a wide spec-
trum of congenital goitrous hypothyroidism, mostly trans-
mitted on the autosomal recessive mode (see Kopp [15] and
references therein).
In the present study, we have identified a new mutation
of the Tg gene in two siblings with congenital goitrous hy-
pothyroidism. This kindred had been previously studied by
us (8). The precise nature of the defect is a splicing error with
total elimination of the exon 30 of the Tg gene, by a G to T
transversion at position 11 in the donor site of intron 30.
Homozygosity is consistent with a recessive trait. The pre-
cise excision of the 138 nt in the Tg mRNA results in an in-
frame deletion of amino acid residues 1832–1877, which is
localized in the Tg type III repeat domain (subtypes: a.2 and
b.1 [2,3]), causing a loss of 1 putative N-linked glycosylation
site. The functional consequences of the deletion are struc-
tural changes in the protein molecule that alter the normal
routing of translation product through the membrane sys-
tem of the cell (16,17). Alternatively, it may impair or sub-
stantially alter the coupling reaction. However, small
amounts of functionally active Tg could be iodinated, and
immediately hydrolized, yielding mostly T3, because of the
intense tissue stimulation by TSH.
A previous report suggests that these patients synthesize
a mutant Tg that is defective for protein folding and assem-
bly, leading to markedly reduced ability to export the pro-
tein from the endoplasmic reticulum with massive induction
of selective synthesis of molecular chaperones, which bind
to the misfolded exportable protein (17). Immunohisto-
chemical localization of Tg data showed that the affected pa-
tients exhibit a marked decrease of reaction product in the
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FIG. 2. Nucleotide sequences of the region of exon 30/intron 30 junction of the patients with congenital goiter showing
the homozygous G R T transversion in position 11 in the donor site of intron 30. Sequence reactions were made with the
same reverse primer (IN 30 R) that was used for genomic amplification. The arrows indicate the G R T transversion. C,
normal control; At.S.N., sister with normal thyroid function; H.S.N. and Ac.S.N., affected individuals.
follicular lumina, with positive reaction product accumu-
lated intracellularly in thyroid epithelial cells. Similar results
were reported for the cog/cog mice (16) and human congen-
ital goiters with other Tg mutations (7).
In addition to the defect in intracellular transport, the ab-
normalities in the coupling machinery may contribute to de-
velopment of the congenital hypothyroid goiters in our pa-
tients. A well-organized three-dimensional Tg structure
plays an important role in the coupling reaction that results
in the fusion of two iodotyrosyl residues. Five hormonogenic
acceptor tyrosines have been identified and localized at po-
sitions 5, 1291, 2554, 2568, and 2747 in human Tg and sev-
eral tyrosines have been proposed as donor sites (18). It is
acceptable that the deletion of 46 residues in the central re-
gion of Tg will affect its tertiary/quaternary structure im-
plying in an altered ability to transfer an iodophenoxyl group
from the donor site to the acceptor iodotyrosine in the cou-
pling machinery.
The phenotype consequences of the defective Tg synthe-
sis were not the same for H.S.N. and Ac.S.N. Although they
shared the same abnormal mutant Tg, Ac.S.N. was only
mildly hypothyroid and developed normally without men-
tal retardation whereas H.S.N. had stunted growth, severe
hypothyroidism, and clinical signs of brain damage (mental
retardation). The major difference between the two siblings
may be related to environmental conditions. Although
Ac.S.N. lived most of her life in a iodine-sufficient environ-
ment (São Paulo), H.S.N. lived mostly in a low-iodine envi-
ronment (a small village in Bahia). In goitrous humans with
defective Tg synthesis (19) and in goitrous goats with a small
mutant Tg transcript (20) excess iodine was able to restore
euthyroidism in spite of marked structural changes in the
mutant Tg. We concluded that the normal daily iodine sup-
ply (Ac.S.N.) was able to induce a normal supply of T3 (but
not T4) that could maintain a certain degree of peripheral eu-
thyroidism at cellular level. By contrast, H.S.N., who was
raised in a low-iodine supply area, could not increase the
synthesis of thyroid hormone in the mutant Tg. This could
explain the different phenotype consequences for each sib-
ling.
In conclusion, we were able to extend our initial studies
in the defective Tg synthesis in this kindred with two af-
fected siblings and a normal sister. In both congenitally
goitrous and hypothyroid patients, a deletion of 138 nt was
identified between positions 5549 and 5686 of the Tg mRNA
corresponding to total elimination of exon 30. The resulting
Tg polypeptide is shortened by 46 residues and may be par-
tially functional for thyroid hormone synthesis in the pres-
ence of a normal iodine intake. The identification of an ad-
ditional mutation in the Tg gene expands our knowledge of
the molecular basis of congenital hypothyroidism and may
provide, by direct sequencing of DNA amplified by PCR, a
rapid prenatal diagnosis, and prevention of fetal hypothy-
roidism.
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